Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

Launched by M.D. ANDERSON CANCER CENTER · Nov 18, 2019

Keywords

ClinConnect Summary

This clinical trial is looking into how the COVID-19 pandemic has affected the financial burdens faced by women with breast cancer who are undergoing breast surgery. Specifically, it examines out-of-pocket costs, lost wages, and unemployment that may arise during this process. The researchers aim to understand whether the pandemic has increased these financial challenges for patients, particularly those who may need breast reconstruction after surgery. By gathering this information, the study hopes to shed light on the economic impact of breast surgery amid the ongoing health crisis.

To participate in this study, women aged 65 to 74 who are English-speaking and are planning to have surgery for invasive breast cancer or ductal carcinoma in situ (a non-invasive type of breast cancer) may qualify. Participants will be asked to complete a survey online, sharing details about their experiences and costs related to their treatment. It’s important to note that women who have recurrent cancer, multiple types of cancer, or who are not planning to have surgery will not be eligible for this trial. Overall, this study aims to provide valuable insights into the financial effects of breast cancer treatment during these challenging times.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Have an indication for surgical treatment of invasive breast cancer or ductal breast carcinoma in situ (DCIS) or prophylaxis in the setting of genetic mutations or strong family history
• • English-speaking
• • Able to complete consent
• • Able to fill out computer survey material
• Exclusion Criteria:
• • Non-English-speaking
• • Those with recurrent or metastatic disease or concurrent primary cancers
• • Patients undergoing breast conservation therapy will also be excluded from the study